Related Experiment Video

Updated: Jun 15, 2026

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
09:36

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

Published on: July 28, 2022

Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis

Dominik D Alexander1, Michael D Cabana

  • 1Exponent Health Sciences Practice, Wood Dale, IL 60191, USA. dalexander@exponent.com

Journal of Pediatric Gastroenterology and Nutrition
|March 11, 2010
PubMed

Insights

Partially hydrolyzed whey protein formula (PHF-W) significantly reduces atopic dermatitis (AD) risk in infants compared to cow's milk formula (CMF). This finding holds true across various study designs, emphasizing PHF-W as a beneficial alternative for non-breastfed infants.

Area of Science:

  • Pediatric Nutrition
  • Dermatology
  • Allergy Research

Background:

  • Several studies suggest a reduced risk of atopic dermatitis (AD) in infants fed partially hydrolyzed whey protein formula (PHF-W) compared to intact protein cow's milk formula (CMF).
  • The potential protective association warrants further investigation to confirm findings and quantify the risk reduction with greater statistical power.

Purpose of the Study:

  • To conduct a meta-analysis of clinical trials and intervention studies.
  • To validate previous observations on the reduced risk of AD with PHF-W formula.
  • To estimate the magnitude of the association between PHF-W formula and reduced AD risk.

Main Methods:

  • A systematic meta-analysis was performed.
  • Inclusion criteria were applied to 18 articles representing 12 independent study populations.
  • Studies included clinical trials and intervention studies evaluating infant formula and AD risk.

Main Results:

  • A statistically significant 44% reduced risk of atopic manifestations, including AD, was observed in infants receiving PHF-W compared to CMF.
  • In a subanalysis of four high-quality studies focusing specifically on AD, the incidence was reduced by 55%.
  • Results were consistent across different study designs, infant populations, follow-up durations, and geographical locations.

Conclusions:

  • Findings consistently demonstrate a reduced incidence of AD in infants fed PHF-W compared to CMF.
  • Exclusive breastfeeding is recommended for infant nutrition in the initial months.
  • For infants not exclusively breastfed, PHF-W formula is a recommended alternative to CMF to reduce AD risk, especially in those with a family history of allergies.
Abstract

More Related Videos

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...